A study discovers a promising new drug therapy for celiac disease
For the first time, researchers have convincing evidence that a medicine for celiac disease can be found. In an international study, a drug candidate called ZED1227 was able to inhibit the activity of transglutaminase 2 (TG2) which triggers celiac disease pathogenesis mechanisms in the mucosa that lines the small intestine.